CCND1 and prostate carcinoma: While not a direct target of phenoxodiol treatment in prostate cancer cells, the role of Cyclin-D1 seems to be tissue and oncogene specific, with Cyclin-D1 linked to activation of the Wnt/β-catenin signalling pathway [33].